Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01459705 · ClinicalTrials.gov registry record · NA

Comparing Virtual Reality Exposure Therapy to Prolonged Exposure

A NA study, sponsored by National Center for Telehealth and Technology.

Completed
Registry status
NA
Development phase
162
Enrollment target

NCT01459705: Completed NA study, sponsored by National Center for Telehealth and Technology.

NCT01459705 is a NA study that has completed, run by National Center for Telehealth and Technology. The registered enrollment target is 162 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01459705, a NA study, has completed, sponsored by National Center for Telehealth and Technology.

COMPLETED
Registry status
NA
Development phase
162 participants
Enrollment target

Study Summary

This study is evaluating the efficacy of virtual reality exposure therapy (VRET) by comparing it to prolonged exposure therapy (PE) and a waitlist(WL) group for the treatment of post traumatic stress disorder (PTSD) in active duty (AD) Soldiers with combat-related trauma. The investigators will test the general hypothesis that 10 sessions of VRET or PE will successfully treat PTSD, therapeutically affect levels of physiological arousal, and significantly reduce perceptions of stigma toward seeking behavioral health services.

Primary Outcome

The CAPS is a structured interview that assesses all Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) PTSD criteria in terms of frequency and intensity. We used total scores as the primary outcome. Minimum possible score was 0, maximum possible score was 136. Higher scores indicated higher levels of symptoms.

Interventions

  • BEHAVIORAL Waitlist
  • BEHAVIORAL Prolonged Exposure Therapy (PE)
  • BEHAVIORAL Virtual Reality Exposure Therapy (VRET)

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2011-10
Est. Completion 2014-05
Phase NA

What the finished NCT01459705 record still lists

NCT01459705 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 3 interventions - of which Waitlist is the first listed.

NCT01459705 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01459705 about?

NCT01459705 is a clinical study titled "Comparing Virtual Reality Exposure Therapy to Prolonged Exposure". This study is evaluating the efficacy of virtual reality exposure therapy (VRET) by comparing it to prolonged exposure therapy (PE) and a waitlist(WL) group for the treatment of post traumatic stress disorder (PTSD) in active duty (AD) Soldiers with combat-related trauma. The investigators will test...

What is the current status of trial NCT01459705?

This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2011-10. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01459705?

The interventions under investigation include: Waitlist (BEHAVIORAL), Prolonged Exposure Therapy (PE) (BEHAVIORAL), Virtual Reality Exposure Therapy (VRET) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01459705?

This trial is sponsored by National Center for Telehealth and Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01459705's enrollment target sits among peer trials

162 627th of 2000 higher than 1,373 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02347111 · 162 participants · Phase 4

    Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

  • NCT02610426 · 162 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

  • NCT05040711 · 162 participants · NA

    mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

  • NCT05514717 · 162 participants · Phase 1

    A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01459705, the US trial registry maintained by the National Library of Medicine. NCT01459705 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.